Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer.Published in:International Journal of Cancer, 2015, v. 137, n. 10, p. 2354, doi. 10.1002/ijc.29613By:Kluth, Martina;Runte, Frederic;Barow, Philipp;Omari, Jazan;Abdelaziz, Zaid M.;Paustian, Lisa;Steurer, Stefan;Christina Tsourlakis, Maria;Fisch, Margit;Graefen, Markus;Tennstedt, Pierre;Huland, Hartwig;Michl, Uwe;Minner, Sarah;Sauter, Guido;Simon, Ronald;Adam, Meike;Schlomm, ThorstenPublication type:Article